Cite
Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways.
MLA
Wang, Rong, et al. “Salvianolic Acid A Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/MTOR, Bcl-2/Bax and Caspase-3/Cleaved Caspase-3 Signaling Pathways.” Drug Design, Development & Therapy, vol. 13, May 2019, pp. 1889–900. EBSCOhost, https://doi.org/10.2147/DDDT.S194787.
APA
Wang, R., Song, F., Li, S., Wu, B., Gu, Y., & Yuan, Y. (2019). Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. Drug Design, Development & Therapy, 13, 1889–1900. https://doi.org/10.2147/DDDT.S194787
Chicago
Wang, Rong, Fuxing Song, Shengnan Li, Bin Wu, Yanqiu Gu, and Yongfang Yuan. 2019. “Salvianolic Acid A Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/MTOR, Bcl-2/Bax and Caspase-3/Cleaved Caspase-3 Signaling Pathways.” Drug Design, Development & Therapy 13 (May): 1889–1900. doi:10.2147/DDDT.S194787.